Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
64.00    2.00 (3.23%)
Bid:
63.00
Ask:
65.00
Spread: 2.00 (3.175%)
Market Cap: £15.59m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Business Update

24 Apr 2024 07:00

RNS Number : 7639L
MyCelx Technologies Corporation
24 April 2024
 

24 April 2024

 

MYCELX TECHNOLOGIES CORPORATION (AIM : MYX)

 

Business Update

 

MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company transforming the environmental impact of industry, is pleased to provide and update on its recent business development.

 

Following the successful completion of the sale of its Saudi Arabian business operations in Q1, the Company has focused its internal resources on accelerating its marketing and sales plan for its unique technologies in the Perfluoroalkyl and Polyfluoroalkyl Substances ("PFAS") remediation and Enhanced Oil Recovery ("EOR") markets. The initial result of this renewed strategy is starting to materialise and accordingly the Company is pleased to provide the following update on these two sectors:

 

PFAS Remediation

 

UNITED STATES

PILOT TRIALS

· Successful completion of treatability study paving the way for inclusion in a multiple technology, four-month pilot trial treating PFAS contamination at a municipal wastewater treatment facility. The trial is expected to commence in Q1 2025, and the final outcome of the trial is expected to determine the award of a lucrative contract by the municipality in 2025.

· Successfully running a short-term, emergency PFAS remediation project treating Aqueous Film Forming Foam ("AFFF") contaminated water at a refinery. Contracted by a global engineering company, MYCELX intends to leverage this success to win more AFFF clean-up projects from the engineering consultant and become their "go-to" solution for AFFF remediation worldwide.

· Ongoing pre-treatment system identification process for a landfill leachate project started in 2024. Currently in discussions with technology partner for pre-treatment equipment to prevent fouling of the MYCELX PFAS system and media.

· Ramped up Rapid Small Scale Column Tests at the Company's Texas facility to perform PFAS water characterisation and removal tests, with the aim of shortening pilot approval and sales cycles.

 

COMMERCIAL and STRATEGIC

· Expect to finalise an agreement with an established Point of Entry/Point of Use commercial and residential water system supplier in the US to integrate the Company's PFAS media into their product line. The recent US Geological Survey report states at least 45% of the nation's tap water is impacted by PFAS contamination. 

· Ongoing discussions with several large, potential partners in each of our PFAS target markets where the parties believe strategically integrating MYCELX's technology creates value for both companies.

 

CORPORATE

· Hired a technical expert with nine years of PFAS experience within a global water treatment and equipment company.

 

AUSTRALIA

· MYCELX is reporting a material uptick in media sales for PFAS systems leased or sold by its Australian distribution partner.

· MYCELX's distribution partner has had recent success in sales of systems.

for PFAS remediation at a liquid waste facility; and

through working with a global engineering firm, sales to three companies to remediate PFAS contaminated water.

 

 

REGEN for EOR and Beneficial Reuse

 

PILOT TRIALS

Middle East

· Currently running a pilot with a global energy technology company to showcase REGEN media's superior capabilities over nutshell media to other EOR producers. We expect to get more traction in the region with EOR producers with whom we have several active proposals.

Canada

· REGEN pilot trial commencing in May with Canadian EOR producer, which, if successful, could potentially result in c.a. $2 million project award.

 

COMMERCIAL and STRATEGIC

· Delivered first REGEN retrofit package contracted in 2023, which will enable our EOR customer in the Middle East to change from traditional nutshell media to REGEN media. We expect more projects with this producer as they retrofit and upgrade equipment and expand production.

· Received notification from a global product supplier to the EOR market that their testing concluded REGEN was the best technology for treatment of EOR produced water and they intend to bid their projects to include REGEN going forward with one bid already submitted.

 

CORPORATE

· Hired an experienced engineer to further strengthen the REGEN team with project start-up and commissioning experience, project proposal production and technical laboratory testing.

 

 

 

Connie Mixon, CEO, commented:

 

"We continue to be upbeat about the progress we have made in 2024 and the outlined developments mentioned reinforce the significant advancements we are making as a business. We intend to capitalise on positive recent developments in the US, following the publishing of the EPA PFAS Drinking Water regulations, and we continue to aggressively pursue partnerships, pilots, data collection and projects in our core markets. There is tremendous opportunity in the EOR market for our REGEN product. We are engaged with multiple producers who require better performance and a reliable solution to water management during production for EOR and beneficial reuse. Both our PFAS and REGEN offerings are designed to be best in class in their applications and we expect to see a continued uptick in demand for sales and/or pilot projects from globally recognisable firms over the rest of 2024."

 

For further information, please contact: 

 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

 

Tel: +1 888 306 6843

Canaccord Genuity Limited (Nomad and Sole Broker)

Henry Fitzgerald-O'Connor

Ana Ercegovic

 

 

Tel: +44 20 7523 8000

Bellicourt Communications (Financial PR)

Mark Anselme

Jimmy Lea

Charlie Denley-Myerson

 

Tel: +44 20 7770 6424

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSEMFWDELSEEL
Date   Source Headline
3rd Jun 20267:00 amRNSAppointment of Non-Executive Director
12th May 20267:00 amRNSNew Gulf of Mexico Lease Award with Super Major
7th May 20267:00 amRNSFinal Results for the Year Ending 31 December 2025
16th Feb 202610:46 amRNSDirector Dealing
20th Jan 20267:00 amRNSTrading Update
22nd Dec 202511:27 amRNSHolding(s) in Company
7th Nov 20252:51 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTrading Update & $3.9m Project Award
1st Oct 20257:00 amRNSHolding(s) in Company
23rd Sep 20255:00 pmRNSResult of Annual Meeting
23rd Sep 20257:00 amRNSAppointment of New Chairman and Succession
17th Sep 20257:00 amRNSHalf Year Results Statement
11th Sep 20257:00 amRNSClosure of Restricted Stock Line
22nd Aug 20257:00 amRNSMailing of Notice of 2025 Annual Meeting
20th Aug 20257:00 amRNSOpening of $500,000 Line of Credit
17th Jul 20257:00 amRNSTrading Update
10th Jun 20257:00 amRNSMailing of 2024 Annual Report
21st May 20253:25 pmRNSDirector Dealing
19th May 202511:33 amRNSHolding(s) in Company
15th May 202511:21 amRNSHolding(s) in Company
12th May 20257:00 amRNSFinal Results for the Year Ending 31 December 2024
6th May 20257:00 amRNSPFAS Contract Award
1st May 20257:00 amRNS-REPA Announces Actions to Combat PFAS Contamination
10th Apr 20257:00 amRNSGrant of Share Options
7th Apr 20257:00 amRNSOperational and Trading Update
30th Jan 20257:00 amRNSChange of Adviser
6th Jan 20257:00 amRNSYear-end Update
29th Oct 20247:00 amRNSProject Award
24th Sep 20247:00 amRNSHalf Year Results Statement
23rd Sep 20247:00 amRNSTrading Update
6th Sep 202411:54 amRNSHolding(s) in Company
5th Sep 20245:17 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSBroker Option
23rd Aug 202411:05 amRNSDirector Dealings & Total Voting Rights
23rd Aug 20247:00 amRNSProposed Placing and Subscription
19th Jul 202410:36 amRNSPFAS Update
9th Jul 20242:23 pmRNSResult of AGM
9th Jul 20241:39 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNS2023 Annual Report & Notice of 2024 Annual Meeting
21st May 20247:00 amRNSDirector Dealing
16th May 20247:00 amRNSFinal Results for the Year Ending 31 December 2023
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.